Veklury Use Expanded in High-Risk COVID-19 Patients
January 21, 2022Savings Opportunities with Upcoming Specialty and Traditional Generics
January 31, 2022
Brand Medications with Generic Alternatives Anticipated to be Approved in February
Selzentry (maraviroc) tablets – for HIV
Adverse reactions or quality problems experienced with the use of a recalled product can be reported to the FDA's MedWatch Adverse Event Reporting Program online, by mail, or by fax.
Submit a Report Online:
https://www.accessdata.fda.gov/scripts/medwatch/index.cfm
Send a Report Via U.S. Mail or Fax: Download a form from https://www.fda.gov/safety/reporting-serious-problems-fda/forms- reporting-fda or call 1-800-332-1088 to request a reporting form. Then complete and return to the address on the form or submit by fax to 1-800-FDA-0178.